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Abstract. Proton computed tomography (pCT) promises to reduce or even eliminate
range uncertainties inherent in the conversion of Hounsfield units into relative stopping
power (RSP) for proton therapy treatment planning. This is of particular interest for
proton irradiation studies in animal models due to the high precision required and
uncertainties in tissue properties.
We propose a dedicated single-particle tracking pCT system consisting of low
material budget floating strips Micromegas detectors for tracking and a segmented
time-projection-chamber with vertical Mylar absorbers, functioning as a range
telescope. Based on Monte Carlo simulations of a realistic in silico beam and
detector implementation, a geometrical optimization of the system components was
conducted to safeguard an ideal operation close to intrinsic performance limits at
75 MeV. Moreover, the overall imaging capabilities relevant for pre-clinical proton
therapy treatment planning were evaluated for a mouse model.
In order to minimize extrinsic uncertainties in the estimated proton trajectories, a
spacing of the two tracking planes of at least 7 cm is required in both tracking detectors.
Additionally, novel in-house developed and produced aluminum-based readout
electrodes promise superior performance with around 3 mm−1 spatial resolution due to
the reduced material budget. Concerning the range telescope, an absorber thickness
within 500µm to 750µm was found to yield the best compromise between water-
equivalent path length resolution and complexity of the detector instrumentation, still
providing sub-0.5% RSP accuracy. The optimized detector configuration enables better
than 2% range accuracy for proton therapy treatment planning in pre-clinical data sets.
This work outlines the potential of pCT for small animal imaging. The performance
of the proposed and optimized system provides superior treatment planning accuracy
compared to conventional X-ray CT. Thus, pCT can play an important role in
translational and pre-clinical cancer research.
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1. Introduction
Pre-clinical in vivo irradiation studies with small animals are of paramount importance
for translational cancer research in order to bridge the gap between in vitro cell
experiments and clinical realization (Tillner et al. 2014). Various research platforms for
photon-based pre-clinical irradiation studies have been developed and commercialized
during the last decade (Verhaegen et al. 2011, Verhaegen et al. 2018). However, those
systems are typically not applicable for nowadays emerging proton beam irradiations,
except for rare cases (Ford et al. 2017).
The main benefit of proton irradiation stems from the characteristic rise in energy
deposition towards the end of the proton beam range, the so-called Bragg peak.
However, the resulting steep dose gradient also bears the risk of inflicting severe damage
to healthy tissue if the proton beam range is not precisely known. A major source of
range uncertainties is the imaging data used for treatment planning, typically relying
on X-ray CTs expressed in the Hounsfield unit (HU) scale. For clinical cases, the
uncertainty inherent in the typically employed stoichiometric conversion of HU values
into the required ion relative (to water) stopping power (RSP) is around 3% (Yang
et al. 2012). Furthermore, for pre-clinical research with mice it is common practice to
employ human reference data for dose calculation (Schyns et al. 2019), due to the limited
availability of detailed information on murine tissue compositions in the literature. This
potentially introduces additional range uncertainties, since the elemental composition
of murine and human tissues can substantially differ.
Proton computed tomography (pCT) represents a promising replacement for X-
ray CT in proton therapy treatment planning since it allows to directly reconstruct
3D RSP distributions. Thus, aforementioned uncertainties originating from the HU-
RSP conversion can be in principle completely eliminated. pCT has experimentally
demonstrated excellent RSP accuracy (Dedes et al. 2019) and simulation studies have
shown superior range calculation accuracy compared to X-ray CT (Meyer et al. 2019).
Moreover, pCT images do not exhibit metal artifacts (Oancea et al. 2018) and can
be obtained at extremely low dose exposure (Schulte et al. 2005), in particular
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if complementary fluence modulation is employed (Dedes et al. 2017, Dickmann
et al. 2019).
Originally proposed in the 1960s, imaging with ion beams has experienced a
revived interest by various research groups worldwide in the last 20 years (Poludniowski
et al. 2015, Johnson 2018). While the main focus is on proton imaging, also heavier
ions like helium or carbon ions have demonstrated promising results due to their
reduced multiple Coulomb scattering (Volz et al. 2017, Gehrke et al. 2018, Magallanes
et al. 2019). State-of-the-art in pCT imaging is the so-called single-particle tracking
technique, which relies on the measurement of individual protons. To this end, pCT
systems consist of two main components: a residual range/energy detector and a
tracking system. The latter typically employs two pairs of 2D position-sensitive tracking
detectors before and behind the imaged object, providing information on proton position
and direction in order to estimate the individual trajectories throughout the object. The
residual energy or range of every transmitted proton is measured with a calorimeter or
range telescope (or hybrid system) placed downstream. This provides the energy lost
by a proton inside the object, which is commonly expressed in terms of water-equivalent
path length (WEPL). Nevertheless, despite tremendous advances in detector technology
and reconstruction algorithms, pCT has not yet entered the clinical environment and is
also barely investigated for pre-clinical imaging.
The SIRMIO project (Parodi et al. 2019) aims to provide a link between proton
beam therapy and pre-clinical research by developing a dedicated platform for small
animal proton irradiation. In order to achieve a high-precision irradiation, the platform
will be equipped with a dedicated pCT system tailored to small animal imaging.
In this work, we present a Monte Carlo (MC) study on the feasibility and
performance of the aforementioned pCT system. For the envisaged construction of
a first prototype, a geometrical design optimization of the detector components was
conducted. This is necessary in order to enable an operation close to the intrinsic
physical performance limits. Furthermore, we evaluated the overall imaging capabilities
and provide the first demonstration of the potential of pCT for treatment planning in
pre-clinical scenarios.
2. Materials and methods
2.1. Principle of proton computed tomography
For proton energies relevant in pCT, i.e., sufficiently high to fully traverse the imaged
object, the mean energy loss dE in matter per unit path length dl is well described by
the Bethe-Bloch (Bethe 1930) equation
−dE (E,~r)
dl
= S (E (~r) I (~r)) , (1)
where S is called (electronic) stopping power and E and I are the proton energy and
material mean excitation energy at position ~r, respectively. Within the context of pCT,
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equation 1 can be rewritten as the integral RSP along a proton trajectory L∫
L
RSP (~r) dl = −
∫ Eout
Ein
dE
Sw (Iw, E)
≡WEPL , (2)
where Sw and Iw are the stopping power and mean excitation energy of water,
respectively. The inverse problem of equation 2 represents the mathematical foundation
of pCT since it enables a direct reconstruction of the 3D RSP distribution inside the
imaged object. Within this work, we employed the iterative ordered-subset simultaneous
algebraic reconstruction technique (Wang & Jiang 2004) coupled to a total variation
superiorization scheme (Penfold et al. 2010) for tomographic image reconstruction.
In order to minimize undesired effects of nuclear reactions and large-angle
scattering, the statistical 3σ event filter (Schulte et al. 2008) was implemented for
parallel-ray projection bins. The air gap surrounding the imaged object was accounted
for by computing a convex hull contour from an initial filtered back projection
reconstruction. Subsequently, a straight line path through the object was assumed
for every proton.
2.2. Detector system and design optimization
The proposed pCT system is based on planar gaseous particle detectors of the
Micromegas (MICRO-MEsh GASeous) type (Giomataris et al. 1996). Micromegas are
asymmetric parallel plate avalanche chambers with a several millimeter wide drift region
and a sub-millimeter amplification region, separated by a thin conductive woven stainless
steel micro-mesh held on supportive pillars. The Townsend electrons are detected at
the charge-sensitive readout strips, which are individually connected to high-voltage and
capacitively coupled to the electronics, so-called ’floating strips’ (Bortfeldt 2014). This
design massively reduces performance deterioration due to nondestructive discharges.
Thus, Micromegas allow to reliably detect individual particles at fluxes of up to
60 MHz/cm2 and enable excellent spatial and good multi-hit resolution (Bortfeldt
et al. 2016).
Within this work, Micromegas detectors in two different functionalities are
investigated. The tracking detectors each consist of a doublet of novel 2D position
sensitive Micromegas tracking detectors (Bortfeldt et al. 2017, Klitzner 2019). Here,
the beam enters perpendicularly to the readout structure, hence, directly providing
2D position information. In the conventional approach, the anode is formed by 33µm
thick photo-lithographically etched copper strips, which are individually connected to
high-voltage. In order to obtain 2D position information, signals are registered via two
additional layers of copper strips (one perpendicular and one parallel with respect to the
floating strips). To reduce the material budget, two modifications of this configuration
are proposed. First, the parallel position information can be directly retrieved by
decoupling signals capacitatively from the floating strips with capacitors outside the
active area, which allows to remove the last strip layer. Additionally, the copper strips
can be replaced by 9 µm thick aluminum strips glued onto insulating Kapton.
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The residual range detector functions as a range telescope and is based on a time-
projection-chamber (TPC) (Marx & Nygren 1978) with Micromegas readout structure
and integrated Mylar field-shaping absorbers placed parallel to the electric drift field. In
order to obtain the best compromise between WEPL resolution and detector complexity,
different absorber thicknesses d={250; 500; 750; 1000} µm were investigated. A proton
track is retrieved from the position information, which is directly measured in horizontal
direction by the readout pads and indirectly inferred in vertical direction from the
measured electron drift time. The residual proton range, i.e., the TPC stage in beam
direction detecting the last energy deposition, can be calibrated to WEPL as explained
later on. A schematic of the complete pCT system is shown in figure 1.
Micromegas-based
time-projection-chamber
with vertical Mylar absorber
Imaged object
(rotatable)
Micromegas doublet 
front tracking system
Micromegas doublet
rear tracking system
Ionization
chamber
d1
d2
Figure 1: Schematic view of the SIRMIO pCT system components, including the
precision dual strip ionization chamber for proton beam monitoring, both during imaging
and treatment. The tracking systems located on both sides of the imaged object each
consist of a doublet of 2D planar Micromegas detectors (separated by a distance d1
and d2 respectively). For measuring the proton residual range, a Micromegas-based
TPC with vertical Mylar absorber plates. For improved visibility, the spacing of the
components is exaggerated.
2.3. Monte Carlo simulation framework
All simulations were performed using the FLUKA (Ferrari et al. 2005, Bo¨hlen et al. 2014)
MC code (version 2011.2x.6 using HADROTHE defaults). The experimental beam
characteristics of a ProBeam R© beam line (Varian Medical Systems, Inc., Palo Alto,
CA, USA) were implemented for scanned proton beams of 75 MeV nominal energy (i.e.,
a range in water of around 46.2 mm), using the approach of Wu¨rl et al. (2016).
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The simulation model of the Micromegas tracking detector system explicitly
considered the used materials and geometries, except for neglecting the fill factor of
the micro-mesh by assuming a homogeneous iron layer of 18µm thickness. In order
to incorporate the expected spatial resolution of the position-sensitive detectors, an
uncertainty (randomly sampled from a normal distribution with conservatively chosen
σ=80 µm (Bortfeldt et al. 2016)) was added to the obtained lateral position values. The
range telescope was modeled as alternating structures of 5 mm wide gas-filled regions
and homogeneous Mylar absorbers. For each proton, the integrated energy deposition
within each gas layer in between two consecutive absorbers was scored through dedicated
FLUKA user routines; however, solely the residual range is later used (i.e., the available
position information at each layer is not employed). Additionally, a model of the parallel
plate ionization chamber, foreseen to be permanently installed in the SIRMIO system
for beam monitoring, was included in the simulation (upstream of the front tracker). All
gaseous detectors contained an 80:20 vol. % mixture of Ne:CF4 at atmospheric pressure
and the electric field was neglected.
The in silico phantom geometries described later on were modeled directly within
the MC simulation according to the their physical dimensions and the manufacturer
material composition specification. X-ray CT data of a mouse (isotropic voxel size
of 0.2 mm) in DICOM format was imported into FLUKA using the standard HU
segmentation into 24 different materials of defined elemental composition and nominal
mean density (Parodi et al. 2007). Electromagnetic processes were re-scaled to match
a bijective clinical-like HU-RSP conversion curve. The knowledge of the exact (i.e.,
error-free) conversion curve allows to directly access the RSP ground truth reference.
2.4. System performance characterization and physical limitations
The achievable RSP accuracy depends on the detector WEPL resolution, which itself
is intrinsically limited by the total range straggling. For a residual range measurement,
this uncertainty is composed of the initial energy spread of the particle beam and
the statistical energy loss fluctuations during the proton slowing-down process. The
latter corresponds to around 1.1% of the mean range (Bashkirov et al. 2016). Based
on the analytical relationship between initial energy E0 and range R according to
Bortfeld (1997) (R = α Ep0 with α = 0.0022 cm/MeV
p and p = 1.77), the additional
range straggling due to the initial Gaussian momentum spread can be derived through
Gaussian error propagation. For the simulated proton beams of 75 MeV nominal energy
with 1% momentum spread the total range straggling equals to 0.83 mm.
The WEPL resolution was quantified according to the procedure of Bashkirov et al.
(2016) by evaluating the detector response for different (water) absorber thicknesses.
In order to quantitatively evaluate the achievable RSP accuracy, the pCT acquisition
of a cylindrical water phantom (∅ 30 mm) with five tissue-equivalent insert rods (∅
6 mm) was simulated (cf. figure 5a). The insert materials were muscle, liver, adipose,
trabecular bone200 and bone400 (CIRS, Inc., Norfolk, VA, USA), and details on the
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elemental composition can be found in Hudobivnik et al. (2016).
The precision of the estimated ion trajectories within the imaged object strongly
influences the spatial resolution of the reconstructed image. In addition to the intrinsic
inaccuracy of the selected trajectory model, the path estimation accuracy depends
on four extrinsic factors, two related to the tracker configuration and two to its
characteristics (Bopp et al. 2014). The latter are given by: (1) the single layer spatial
resolution of the position-sensitive tracking detectors and (2) the material budget of
the innermost (i.e., facing the imaged object) layer of the Micromegas doublet, which
determines the amount of scattering a particle undergoes without the possibility to
measure it. The limitations due to the tracker configuration can be characterized by: (3)
the spacing between the individual sub-systems/layers within one Micromegas doublet
(i.e., d1 and d2 in figure 1) and (4) the distance between object and tracker module,
causing an amplification of uncertainties in position and direction estimation.
The path estimation accuracy was investigated in simulations of a 2 cm thick water
phantom. The root mean square (RMS) deviation between the actual MC proton
trajectories and the estimated paths was calculated for 105 proton histories at 41
equally spaced points along the paths. Moreover, the pCT image spatial resolution
was quantified using a slanted-edge phantom (i.e., a water phantom with a square insert
of 8 mm side length and 2◦ inclination as shown in figure 3a) (Mori & Machida 2009).
Due to the symmetry of the phantom, an average composite edge-spread function was
obtained by combining the oversampled profiles from each side of the insert. The spatial
resolution is quantified in terms of the 10% modulation transfer function.
2.5. Small animal treatment planning
To investigate the suitability for treatment planning of the reconstructed pCT images,
a research version of the MC-based proton treatment planning system µ-RayStation
(RaySearch Laboratories, Stockholm, Sweden) was used. Prior to the data import
the images were back-converted into HUs using the inverse HU-RSP conversion curve
implemented in the MC simulations. Due to the imposed bijectivity of that function,
no uncertainty or ambiguity is introduced by this procedure (Meyer et al. 2019).
Treatment plans were optimized on the ground truth using the beam properties of
the SIRMIO beam line, obtained from validated MC simulations (Parodi et al. 2019,
Kurichiyanil et al. 2019), and subsequently recalculated on the pCT images. The
dosimetric agreement was quantified in terms of (water-equivalent) beam’s-eye view
range differences (Meyer et al. 2019) for a hypothetical brain and lung tumor treatment.
3. Results
3.1. Tracking detector performance and optimization
The Micromegas spatial resolution is i.a. determined by the pitch of the readout strips
and is (conservatively) assumed to yield 80µm. Moreover, the distance between detector
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front face and isocenter must allow sufficient space for the object being imaged and is
consequently fixed at 4 cm. Since the intrinsic path model uncertainty is rather low
(i.e., maximum RMS error of 0.07 mm) due to the limited amount of multiple Coulomb
scattering inside of 2 cm water, only two points for optimization remain: the spacing
between the individual Micromegas planes in a doublet and their material budget.
The total RMS path estimation deviation for the three different readout structure
configurations is shown in figure 2a as a function of depth inside the water phantom.
The average (i.e., for the entire path within the object) RMS path deviation for the
configuration with aluminum strips was around 0.29 mm, and thus 0.07 mm and 0.10 mm
lower than for the copper-based designs with two and three layers of strips in the readout
structure, respectively.
The distance between the inner and outer detector of each Micromegas doublet
influences the precision of the track angle measurement. Hence, the distance between
the layers in the upstream and downstream tracker doublets was varied from 1 cm to
10 cm in 0.5 cm increments independent of one another. For the detector system with
aluminum strip readout the resulting surface plot of the average RMS path estimation
error is shown in figure 2b. Increasing upstream and downstream tracker spacing to more
than around 7 cm did not considerably improve the path accuracy. This configuration
yielded an average RMS path deviation of 0.18 mm. As a cautious choice to avoid
potential spatial resolution degradation in the image, 10 cm spacing of the tracker sub-
systems will be used for front and rear tracker hereafter.
For the aluminum-based design, the reconstructed pCT image of the slanted-edge
phantom and the regions used for the construction of the oversampled edge profile can
be seen in figure 3a. The resulting modulation transfer functions for the different tracker
configurations are shown in figure 3b. The obtained spatial resolution was 1.9 mm−1,
2.2 mm−1 and 2.8 mm−1 for the copper-based designs with three and two layers, and the
aluminum strips configuration, respectively. The results are close to the performance
of an ideal tracker system (obtained by using the MC information on the particles’
position and direction at the entrance/exit of the tracking modules), which enabled a
spatial resolution of 3.4 mm−1.
3.2. Range telescope performance and optimization
The range-to-WEPL calibration plots are shown in figure 4a. Based on the established
linear calibration function, the standard deviation of the detector response can be
translated into WEPL standard deviation by using Gaussian error propagation. The
resulting WEPL resolutions as a function of WEPL being imaged are shown in figure
4b. As expected, the value generally improves towards thinner absorbers and is
mostly constant except for statistical fluctuations. For increasing absorber thicknesses
a systematically deteriorated performance toward lower WEPL values can be observed.
An exemplarily reconstructed pCT slice of the cylindrical insert phantom can be
seen in figure 5a. The corresponding RSP accuracy for the insert materials achieved
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Figure 2: (a) Comparison of the total RMS path estimation error for the three different
readout structure designs. (b) Surface plot of the average (i.e., for the entire path
within the object) RMS path estimation error for the aluminum-based readout structure
configuration as a function of upstream and downstream detector separation.
for different absorber thicknesses is displayed as bar plot in figure 5b, reflecting the
improved WEPL resolution for thinner absorber slabs. Overall, sub-1% RSP accuracy
was demonstrated; however, results for 1000 µm absorber thickness resulted in image
artifacts of slightly distorted insert geometries. The mean RSP accuracy was 0.53%,
0.27%, 0.24% and 0.22% for the designs with a granularity of 1000 µm, 750 µm, 500 µm
and 250 µm Mylar, respectively.
3.3. Imaging of pre-clinical data sets
Figure 6a shows the reconstructed pCT images of a mouse head for the optimized
detector system (i.e., aluminum-based tracking detector layers, spaced 10 cm, and TPC
with 500µm thick Mylar absorbers) along with the ground truth and the result for an
ideal detector. The images were obtained for a dose exposure of (93 ± 5) mGy. While
the images clearly resemble the reference anatomy at a low noise level, blurring due to
the limited spatial resolution is immanent. The corresponding RSP distributions are
displayed as joint histogram in figure 6b for the realistic detector model. The mean
RSP for bone-like materials (HU>1200) and soft tissue-tissue (−500 <HU< 0) are
underestimated by up to 0.15.
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Figure 3: (a) Reconstructed pCT image of the slanted-edge phantom using an optimized
aluminum-based tracker system. The indicated rectangles are the regions used for the
construction of the oversampled edge profile and the viewing window is set between RSP
values of 0.7 (black) and 1.7 (white). (b) Comparison of the corresponding modulation
transfer functions for the different tracker configurations along with an ideal system.
3.4. Treatment planning accuracy
Figure 7 exemplary shows the optimized single field uniform dose distributions along
with the results for plan recalculations on the reconstructed pCT images. In both cases,
pCT enabled sub-millimeter accuracy with an average (±1σ) relative proton-beam range
error of (−0.02± 1.42)% and (+0.87± 0.98)% for the lung and brain case, respectively.
The corresponding absolute water-equivalent range differences are (−0.01 ± 0.20) mm
and (+0.09± 0.10) mm.
4. Discussion
4.1. Detector optimization
Both proposed modifications of the design of previously existing tracking detectors
resulted in a substantial performance benefit. Moving the layer of parallel readout strips
out of the active area reduces the total material budget by around 33%. The aluminum-
based design exhibits 3.7 times lower overall metal thickness (from 33µm down to 9µm)
with about six times larger radiation length compared to copper (8.897 cm and 1.436 cm
respectively). These changes will substantially reduce multiple Coulomb scattering in
the tracking detectors, which scales with the square-root of the material budget. Hence,
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Figure 4: (a) Simulated calibration plots for the different TPC-based range telescope
configurations: WEPL value versus range inside the detector obtained as mean value of
the Gaussian fit. The black lines are linear fits used to extract the calibration functions.
(b) WEPL resolution plots for the different TPC-based range telescope configurations
as a function of WEPL being imaged: the intrinsic range straggling limit is indicated
by the dashed gray line and the shaded area represents the 95% confidence interval
obtained from the Gaussian fits.
these changes limit the amount of scattering a particle undergoes without the possibility
to measure it. The path accuracy increases towards the object center (cf. figure 2a)
since the information from both trackers is combined. In contrast, the intrinsic path
model inaccuracy for relevant objects due to the stochastic nature of multiple Coulomb
scattering, which is largest slightly downstream the center of the object, is rather small.
For the same reason, the benefit of sophisticated proton path estimation models like the
cubic spline path (Collins-Fekete et al. 2015) or most likely path (Schulte et al. 2008)
over the computationally efficient straight line path is limited. In addition, the finite
angular precision of the detector system is causing increased inaccuracies for those
models exploiting the measured proton direction, in particular at the entrance and
exit of the object. This can even lead to a superior performance of the straight line
path for certain objects.
While the ideal detector layer spacing for the presented irradiation scenario was
above 7 cm, the value for the separation of the upstream tracker planes will generally
depend on the absolute angular value (i.e., the divergence of the incident proton
beam) since the angular uncertainty decreases with increasing absolute angular value.
Furthermore, the optimum downstream value will vary according to the proton residual
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Figure 5: (a) Reconstructed pCT image of the cylindrical insert phantom obtained for an
absorber thickness of 500µm. The viewing window is set between RSP values of 0.7 and
1.7. (b) RSP relative error distributions for different absorber thicknesses displayed as
bar plot. The bars correspond to the mean relative error values and whiskers represent
the ±1σ intervals.
energy (i.e., shape and water-equivalent thickness of the object) (Penfold et al. 2011).
This justifies the previous choice of 10 cm despite the reduced detector compactness.
Concerning the TPC, an absorber thickness between 500 µm and 750 µm represents
the best trade-off between achievable WEPL/RSP resolution and detector complexity,
since a larger quantity of thinner absorbers (and readout channels) would be required
to enable the same dynamic WEPL range. The slightly degraded WEPL resolution
toward smaller WEPL values (cf. figure 4b) might be a consequence of the large residual
range within the TPC of the corresponding protons. Scattering and the initial particle
direction could accumulate to a detectable difference between the CSDA range within the
detector and the actually measured projected range in beam direction. This effect can
potentially be compensated by applying an advanced residual range calibration. Future
improvements could also encompass a more sophisticated event filtering as proposed by
Volz et al. (2019) in conjunction with embedding the available TPC proton trajectory
information.
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Figure 6: (a) Exemplary reconstructed pCT images for a mouse head obtained for
an aluminum-based tracker and TPC with 500µm thick absorber foils along with the
ground truth. (b) Corresponding joint histogram of the reconstructed RSP and the
original HU values. The red line indicates the ground truth conversion curve being used
to import the initial X-ray CT data into the MC simulation. The curve below shows
the corresponding mean RSP error (±1σ).
4.2. Imaging performance
The obtained spatial resolution of around 3 mm−1 for the optimized pCT system is
comparable to the performance of cone beam CT systems commonly used in pre-clinical
research (Song et al. 2010). However, the level of detail visible in the presented pCT
reconstructions for realistic small animal data (cf. figure 6a) appears slightly inferior to
the estimated spatial resolution based on the phantom study. One reason is the highly
heterogeneous 3D anatomy, which creates additional path uncertainties compared to
the rotationally symmetric homogeneous phantom case. Nevertheless, the observed
sub-0.5% RSP accuracy of pCT is expected to be substantially superior to X-ray CT
imaging. The observed systematic minor RSP underestimation (cf. figure 5b) is also
reflected in the reconstructions for pre-clinical data (cf. figure 6b). This once again
promotes the investigation of more sophisticated TPC-range calibration methods.
For the study of pre-clinical small animal data, the mouse holder being developed
in-house for the SIRMIO project was not included in the simulation. It consists of
a rigid yet low material budget fixation system, heating and connections for air and
anesthesia supply. In order to guarantee a sterile environment for immunodeficient
mice, the chamber will be surrounded by a nearly cylindrical shell consisting of a 50µm
thin Kapton foil (Parodi et al. 2019). To further reduce scattering for ultra-precise
irradiation, the support bed will contain cutouts (sealed with a thin Kapton foil) at
Proton CT for pre-clinical imaging 14
Figure 7: Treatment plans for a hypothetical lung (left) and brain (right) tumor case in
a mouse model. Relative dose distributions (with respect to the prescribed target dose)
are shown for the optimized reference plans and the recalculated ones (i.e., on the pCT
images) along with the corresponding relative dose differences.
irradiation locations specific to the treated indiciation. In order to compensate the
potential deterioration of the pCT spatial resolution due to the additional material the
tracking system could be moved slightly closer towards the holder.
4.3. Treatment planning accuracy
The observed range inaccuracies result as combination of limited RSP accuracy and
spatial resolution. For the rather homogenous brain case, the uncertainty is dominated
by the slight RSP underestimation for soft tissue, which accumulates to the detected
over-ranging. In contrast, the lung case is dominated by heterogeneities, resulting
in a better mean accuracy but increased standard deviation. Considering that a
stoichiometric HU-RSP conversion based on human reference tissues for small animal
irradiation will result in range uncertainties above 3%, pCT is able to provide improved
treatment planning accuracy compared to conventional X-ray CT. Moreover, pre-clinical
imaging commonly only employs cone beam CT systems, which are typically providing
only limited image quality. The pCT system will enable imaging of mice directly in
treatment position (including a correction of the proton beam position via the installed
ionization chamber).
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4.4. Potential limitations of an experimental realization
The detector system simulated in this study provides accurate imaging capabilities,
however, there are some potential limitations regarding the translation from in silico
to experimental realization. First, the manufacturing and structuring process of
the aluminum-based Micromegas is more sophisticated compared to the conventional
copper design and requires certain adjustments. Nevertheless, the process has been
completely mastered in-house and a first prototype has been already produced and
sucessfully tested in 22 MeV proton beams. No aging has been observed. A detailed
evaluation of the actual position resolution, which is possibly even better than the
assumed 80µm is ongoing. The functional principle of the proposed TPC configuration
has been demonstrated with a first prototype (La¨mmer 2019). A reliable electron
extraction within the active region in between two consecutive Mylar plates is has been
demonstrated for 6 mm absorber spacing using field-shaping foils.
5. Conclusion
The presented work is the first detailed investigation of the potential of pCT with
a single-particle tracking system for small animal imaging. It provides a thorough
MC-based optimization of the detector configuration and quantitatively evaluates the
expected performance with respect to the requirements for pre-clinical research. Both
components of the pCT system are currently under construction in-house and first
prototypes have been successfully tested in proton beams, underlining the feasibility
of the proposed system. While proton imaging is nowadays on the verge of becoming
clinically available, the proposed pre-clinical system will contribute to an improved
precision of small animal proton irradiations. This might help to provide a better
understanding of the fundamental in vivo characteristics of cancer and normal tissue
response to ion radiation exposure.
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